Akebia Therapeutics Announces First Commercial Launch of VAFSEO(TM) (vadadustat tablets), a New Oral Treatment for Anemia Due to Chronic Kidney Disease, in Japan

VAFSEO Launch Marks Availability of Convenient Once-Daily Oral Treatment for Adult Patients on Dialysis and Not on Dialysis in Japan CAMBRIDGE, Mass., Aug. 26, 2020 -- (Healthcare Sales & Marketing Network) -- Akebia Therapeutics®, Inc. (Nasdaq: AK... Biopharmaceuticals, Product Launch Akebia Therapeutics, vadadustat, VAFSEO , chronic kidney disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news